Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Appl Microbiol ; 129(6): 1511-1522, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32492264

RESUMEN

AIMS: The objective of this study was to determine the effects of Ca-dipicolinic acid (CaDPA), cortex-lytic enzymes (CLEs), the inner membrane (IM) CaDPA channel and coat on spore killing by dodecylamine. METHODS AND RESULTS: Bacillus subtilis spores, wild-type, CaDPA-less due to the absence of DPA synthase or the IM CaDPA channel, or lacking CLEs, were dodecylamine-treated and spore viability and vital staining were all determined. Dodecylamine killed intact wild-type and CaDPA-less B. subtilis spores similarly, and also killed intact Clostridiodes difficile spores ± CaDPA, with up to 99% killing with 1 mol l-1 dodecylamine in 4 h at 45°C with spores at ~108  ml-1 . Dodecylamine killing of decoated wild type and CLE-less B. subtilis spores was similar, but ~twofold faster than for intact spores, and much faster for decoated CaDPA-less spores, with ≥99% killing in 5 min. Propidium iodide stained intact spores ± CaDPA minimally, decoated CaDPA-replete spores or dodecylamine-killed CLE-less spores peripherally, and cores of decoated CaDPA-less spores and dodecylamine-killed intact spores with CLEs. The IM of some decoated CaDPA-less spores was greatly reorganized. CONCLUSIONS: Dodecylamine spore killing does not require CaDPA channels, CaDPA or CLEs. The lack of CaDPA in decoated spores allowed strong PI staining of the spore core, indicating loss of these spores IM permeability barrier. SIGNIFICANCE AND IMPACT OF THE STUDY: This work gives new information on killing bacterial spores by dodecylamine, and how spore IM's relative impermeability is maintained.


Asunto(s)
Aminas/farmacología , Antibacterianos/farmacología , Bacillus subtilis/efectos de los fármacos , Membrana Celular/efectos de los fármacos , Esporas Bacterianas/efectos de los fármacos , Bacillus subtilis/genética , Bacillus subtilis/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Membrana Celular/metabolismo , Permeabilidad de la Membrana Celular , Mutación , Ácidos Picolínicos/metabolismo , Esporas Bacterianas/metabolismo
2.
Int J Cardiol ; 187: 604-13, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25863735

RESUMEN

PURPOSE: Atrial fibrillation (AF) has been associated with increased volumes of epicardial fat and atrial adipocyte accumulation. Underlying mechanisms are not well understood. This study aims to identify rapid atrial pacing (RAP)/AF-dependent changes in atrial adipocyte/adipositas-related gene expression (AARE). METHODS: Right atrial (RA) and adjacent epicardial adipose tissue (EAT) samples were obtained from 26 patients; 13 with AF, 13 in sinus rhythm (SR). Left atrial (LA) samples were obtained from 9 pigs (5 RAP, 4 sham-operated controls). AARE was analyzed using microarrays and RT-qPCR. The impact of diabetes/obesity on gene expression was additionally determined in RA samples (RAP ex vivo and controls) from 3 vs. 6 months old ZDF rats. RESULTS: RAP in vivo of pigs resulted in substantial changes of AARE, with 66 genes being up- and 53 down-regulated on the mRNA level. Differential expression during adipocyte differentiation was confirmed using 3T3-L1 cells. In patients with AF (compared to SR), a comparable change in RA mRNA levels concerned a fraction of genes only (RETN, IGF1, HK2, PYGM, LOX, and NR4A3). RA and EAT were affected by AF to a different extent. In patients, concomitant disease contributes to AARE changes. CONCLUSIONS: RAP, and to lesser extent AF, provoke significant changes in atrial AARE. In chronic AF, activation of this gene panel is very likely mediated by AF itself, AF risk factors and concomitant diseases. This may facilitate the development of an AF substrate by increasing atrial ectopic fat and fat infiltration of the atrial myocardium.


Asunto(s)
Adipocitos/metabolismo , Fibrilación Atrial/genética , Fibrilación Atrial/terapia , Estimulación Cardíaca Artificial/métodos , Proteínas de la Matriz Extracelular/genética , Regulación de la Expresión Génica/fisiología , Anciano , Animales , Apéndice Atrial/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pericardio/patología , Ratas , Ratas Zucker , Reacción en Cadena en Tiempo Real de la Polimerasa , Porcinos
3.
Clin Chest Med ; 22(1): 209-17, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11315457

RESUMEN

The chronically critically ill are a challenging population of patients. Their mortality rate is high and expected functional status is low. The physician responsible for the care of these patients often is conflicted because the gains experienced by these patients may be small or absent whereas the pressure by society to use medical resources better is great. This pressure leads to the need for making difficult decisions on issues ranging from the initiation of acute care to withholding and withdrawing of care at the end of life. By understanding the ethical principles that govern decision-making, the physician can guide patients and their families toward realistic expectations.


Asunto(s)
Cuidados Críticos , Ética Médica , Enfermedades Pulmonares Obstructivas/terapia , Insuficiencia Respiratoria/terapia , Humanos , Enfermedades Pulmonares Obstructivas/etiología , Inutilidad Médica , Principios Morales , Grupo de Atención al Paciente , Calidad de Vida , Insuficiencia Respiratoria/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...